Development of a nonhuman primate challenge model to evaluate CD8+ T cell responses to an adenovirus-based vaccine expressing SIV proteins upon repeat-dose treatment with checkpoint inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of a nonhuman primate challenge model to evaluate CD8+ T cell responses to an adenovirus-based vaccine expressing SIV proteins upon repeat-dose treatment with checkpoint inhibitors

Published:2021-12-20 Issue:1 Volume:14 Page:
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Graveline Richard¹,Haida Morad¹,Dumont Carolyne¹,Poulin Dominic¹,Poitout-Belissent Florence¹,Samadfam Rana¹,Kronenberg Sven²,Regenass-Lechner Franziska²,Prell Rodney³,Piche Marie-Soleil¹

Affiliation:

1. Immunology, Charles River Laboratories, Senneville, Canada

2. Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland

3. Safety Assessment, Development Sciences, Genentech, South San Francisco, CA, USA

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/19420862.2021.1979447

Reference57 articles.

1. Oncology Meets Immunology: The Cancer-Immunity Cycle

2. The safety, efficacy and regulatory triangle in drug development: Impact for animal models and the use of animals

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges and gaps in immunosafety evaluation of therapeutics: An IQ DruSafe survey;Regulatory Toxicology and Pharmacology;2024-06

2. Current approaches to evaluate the function of cytotoxic T-cells in non-human primates;Journal of Immunotoxicology;2023-02-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP